Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

Home Stock Screener Document Search Charting Watchlists Recent Filings

Fuse Medical, Inc.(FZMD US)

$0.03+0.000.00%(Market Open · 21:00:00 UTC)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Categorized Chronological By Owner

Financials & Metrics

Financials Charting Short Interest Employees

Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

Home Stock Screener Document Search Charting Watchlists Recent Filings

Fuse Medical, Inc.(FZMD US)

$0.03+0.000.00%(Market Open · 21:00:00 UTC)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Categorized Chronological By Owner

Financials & Metrics

Financials Charting Short Interest Employees

FZMD US

FZMD US

Chronological SEC Filings

Chronological SEC Filings

Non-Ownership Filings(273)

15-12GNotice of suspension of duty to file27 Sep 2023
8-KResults of Operations and Financial Condition27 Sep 2023
8-KResults of Operations and Financial Condition15 Aug 2023
10-QQ2ended 30 Jun 202314 Aug 2023
8-KSubmission of Matters to Shareholder Vote26 Jun 2023
10-QQ1ended 31 Mar 202315 May 2023
DEFA14ADefinitive additional materials10 May 2023
ARSAnnual report to security holders10 May 2023
DEF 14ADefinitive proxy statement10 May 2023
8-KFOR IMMEDIATE RELEASE18 Apr 2023
10-KFY 2022ended 31 Dec 202214 Apr 2023
NT 10-KFY 2022ended 31 Dec 20223 Apr 2023
8-KChange in Certifying Accountant22 Nov 2022
8-KSeptember 30,2022December 31,2021(Unaudited)AssetsCurrent assets:Cash$505,989$553,190Accounts receivable, net of allowance of $392,135 and $498,261, respectively2,625,9493,528,992Inventories9,850,6828,736,474Prepaid expenses and other current assets33,7125,921Total current assets13,016,33212,824,577Property and equipment, net399,9487,251Long term accounts receivable, net of allowance of $3,937,568 and $3,355,391, respectively2,570,5542,182,437Intangible assets, net1,223,6951,317,341Goodwill1,972,8861,972,886Total assets$19,183,415$18,304,492Liabilities and Stockholders' Equity (Accumulated Deficit)Current liabilities:Accounts payable$4,822,278$4,461,641Accrued expenses4,244,4002,898,068Convertible notes payable - related parties150,000150,000Notes payable - related parties200,000200,000Senior secured revolving credit facility2,044,6062,432,770Total current liabilities11,461,28410,142,479Earn-out liability11,593,83211,593,832Total liabilities23,055,11621,736,311Commitments and contingencies--Stockholders' equity (accumulated deficit)Preferred stock, $0.01 par value; 20,000,000 shares authorized, no shares issued andoutstanding--Common stock, $0.01 par value; 100,000,000 shares authorized, 72,895,793 shares issued and outstanding as of June 30, 2022 and December 31, 2021.728,958728,958Additional paid-in capital1,476,5161,455,422Accumulated deficit(6,077,175)(5,616,199)Total stockholders' equity (accumulated deficit)(3,871,701)(3,431,819)Total liabilities and stockholders' equity (accumulated deficit)$19,183,415$18,304,49218 Nov 2022
10-QQ3ended 30 Sept 202214 Nov 2022
10-QQ2ended 30 Jun 202211 Aug 2022
8-KSubmission of Matters to Shareholder Vote28 Jun 2022
10-QQ1ended 31 Mar 202212 May 2022
DEFA14ADefinitive additional materials10 May 2022
DEF 14ADefinitive proxy statement10 May 2022

Ownership Filings(109)

Form 4Reeg Christopher C16 Dec 2022
Form 4Brooks Mark W16 Dec 2022
Form 4Yellin Lawrence Scott16 Dec 2022
Form 4Brooks Mark W17 Nov 2022
Form 3Yellin Lawrence Scott26 May 2022
Form 5Reeg Christopher C23 Feb 2022
Form 5Brooks Mark W23 Feb 2022
Form 4Bosita Renato V. Jr.21 Dec 2018
Form 4Kalra Ricky Raj S.14 Dec 2018
Form 4Brooks Mark W14 Dec 2018
Form 4Reeg Christopher C14 Dec 2018
Form 4McLaughlin William E III14 Dec 2018
Form 4/AReeg Medical Industries, Inc.27 Nov 2018
Form 4/AReeg Christopher C27 Nov 2018
SC 13D/AFuse Medical, Inc.13 Aug 2018
SC 13D/AFuse Medical, Inc.13 Aug 2018
Form 4Reeg Medical Industries, Inc.3 Aug 2018
Form 4Reeg Christopher C3 Aug 2018
Form 3/AReeg Medical Industries, Inc.8 Feb 2018
Form 4/ABrooks Mark W8 Feb 2018

Non-Ownership Filings(273)

15-12GNotice of suspension of duty to file27 Sep 2023
8-KResults of Operations and Financial Condition27 Sep 2023
8-KResults of Operations and Financial Condition15 Aug 2023
10-QQ2ended 30 Jun 202314 Aug 2023
8-KSubmission of Matters to Shareholder Vote26 Jun 2023
10-QQ1ended 31 Mar 202315 May 2023
DEFA14ADefinitive additional materials10 May 2023
ARSAnnual report to security holders10 May 2023
DEF 14ADefinitive proxy statement10 May 2023
8-KFOR IMMEDIATE RELEASE18 Apr 2023
10-KFY 2022ended 31 Dec 202214 Apr 2023
NT 10-KFY 2022ended 31 Dec 20223 Apr 2023
8-KChange in Certifying Accountant22 Nov 2022
8-KSeptember 30,2022December 31,2021(Unaudited)AssetsCurrent assets:Cash$505,989$553,190Accounts receivable, net of allowance of $392,135 and $498,261, respectively2,625,9493,528,992Inventories9,850,6828,736,474Prepaid expenses and other current assets33,7125,921Total current assets13,016,33212,824,577Property and equipment, net399,9487,251Long term accounts receivable, net of allowance of $3,937,568 and $3,355,391, respectively2,570,5542,182,437Intangible assets, net1,223,6951,317,341Goodwill1,972,8861,972,886Total assets$19,183,415$18,304,492Liabilities and Stockholders' Equity (Accumulated Deficit)Current liabilities:Accounts payable$4,822,278$4,461,641Accrued expenses4,244,4002,898,068Convertible notes payable - related parties150,000150,000Notes payable - related parties200,000200,000Senior secured revolving credit facility2,044,6062,432,770Total current liabilities11,461,28410,142,479Earn-out liability11,593,83211,593,832Total liabilities23,055,11621,736,311Commitments and contingencies--Stockholders' equity (accumulated deficit)Preferred stock, $0.01 par value; 20,000,000 shares authorized, no shares issued andoutstanding--Common stock, $0.01 par value; 100,000,000 shares authorized, 72,895,793 shares issued and outstanding as of June 30, 2022 and December 31, 2021.728,958728,958Additional paid-in capital1,476,5161,455,422Accumulated deficit(6,077,175)(5,616,199)Total stockholders' equity (accumulated deficit)(3,871,701)(3,431,819)Total liabilities and stockholders' equity (accumulated deficit)$19,183,415$18,304,49218 Nov 2022
10-QQ3ended 30 Sept 202214 Nov 2022
10-QQ2ended 30 Jun 202211 Aug 2022
8-KSubmission of Matters to Shareholder Vote28 Jun 2022
10-QQ1ended 31 Mar 202212 May 2022
DEFA14ADefinitive additional materials10 May 2022
DEF 14ADefinitive proxy statement10 May 2022

Ownership Filings(109)

Form 4Reeg Christopher C16 Dec 2022
Form 4Brooks Mark W16 Dec 2022
Form 4Yellin Lawrence Scott16 Dec 2022
Form 4Brooks Mark W17 Nov 2022
Form 3Yellin Lawrence Scott26 May 2022
Form 5Reeg Christopher C23 Feb 2022
Form 5Brooks Mark W23 Feb 2022
Form 4Bosita Renato V. Jr.21 Dec 2018
Form 4Kalra Ricky Raj S.14 Dec 2018
Form 4Brooks Mark W14 Dec 2018
Form 4Reeg Christopher C14 Dec 2018
Form 4McLaughlin William E III14 Dec 2018
Form 4/AReeg Medical Industries, Inc.27 Nov 2018
Form 4/AReeg Christopher C27 Nov 2018
SC 13D/AFuse Medical, Inc.13 Aug 2018
SC 13D/AFuse Medical, Inc.13 Aug 2018
Form 4Reeg Medical Industries, Inc.3 Aug 2018
Form 4Reeg Christopher C3 Aug 2018
Form 3/AReeg Medical Industries, Inc.8 Feb 2018
Form 4/ABrooks Mark W8 Feb 2018